trial

Cognitive Remediation Therapy Within a Secure Forensic Setting

NCTId NCT02360813
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 65 (actual)
Sponsored by Central Mental Hospital
Primary completion 2017-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
65 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2014-08
Primary completion
2017-01
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Cognitive Remediation Therapy

Sponsors

Central Mental HospitalLead Sponsor

Investigators

3
Professor Harry G Kennedy, M.D.Study Director
Professor Gary Donohoe, Ph.D.Study Director
Dr. Ken W O'Reilly, D.Psych.Sc.Principal Investigator

Sites

1 total
Dublin, Ireland

Facts & assertions

4 sourced
Enrollment
65
Phase
NA
Primary Completion Date
2017-01
Status
COMPLETED
relationships
The graph out of here
drug
Cognitive Remediation Therapy
drug
lead_sponsor
Central Mental Hospital
company
indication
Schizoaffective Disorder
indication
Psychotic Disorders
indication
Schizophrenia
indication
investigator
Professor Harry G Kennedy, M.D.
person
Professor Gary Donohoe, Ph.D.
person
Dr. Ken W O'Reilly, D.Psych.Sc.
person